Michael S. Ostrach
2012 - Dynavax Technologies
In 2012, Michael S. Ostrach earned a total compensation of $1.5M as Vice President, Chief Financial Officer, Chief Business Officer and General Counsel at Dynavax Technologies, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,759 |
|---|---|
| Option Awards | $562,608 |
| Salary | $332,210 |
| Stock Awards | $422,000 |
| Other | $27,809 |
| Total | $1,469,386 |
Ostrach received $562.6K in option awards, accounting for 38% of the total pay in 2012.
Ostrach also received $124.8K in non-equity incentive plan, $332.2K in salary, $422K in stock awards and $27.8K in other compensation.
Rankings
In 2012, Michael S. Ostrach's compensation ranked 4,640th out of 11,487 executives tracked by ExecPay. In other words, Ostrach earned more than 59.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,640 out of 11,487 | 60th |
Division Manufacturing | 1,619 out of 4,253 | 62nd |
Major group Chemicals And Allied Products | 370 out of 1,198 | 69th |
Industry group Drugs | 232 out of 920 | 75th |
Industry Pharmaceutical Preparations | 180 out of 700 | 74th |
Source: SEC filing on April 21, 2015.
Ostrach's colleagues
We found seven more compensation records of executives who worked with Michael S. Ostrach at Dynavax Technologies in 2012.
2012
Dino Dina
Dynavax Technologies
Chief Executive Officer
2012
J Martin
Dynavax Technologies
Chief Medical Officer
2012
Stephen Tuck
Dynavax Technologies
Former Vice President, Global Technical Operations
2012
Robert Coffman
Dynavax Technologies
Chief Scientific Officer
2012
Christine Larson
Dynavax Technologies
Chief Financial Officer
2012
Jennifer Lew
Dynavax Technologies
Former Vice President, Finance and Former Principal Accounting Officer
2012
Robert Janssen
Dynavax Technologies